• Home >
  • Overview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa

Overview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa

The other diseases of the Millennium Development Goal 6

19-Apr-2012  /  Research Code: M70B-01-00-00-00  /  SKU: HC01930-AF-MR_07036  /  
Region: Africa

Regular Price: USD 6,950.00

Special Price USD 5,212.50

25% OFF

* Required Fields

Regular Price: USD 6,950.00

Special Price USD 5,212.50

PAY BY INVOICE

Be the first to review this product

Research was carried out on the orphan disease and related drug space in Sub-Saharan Africa with emphasis on 5 countries, namely, Ghana, Nigeria, Uganda, Kenya and Tanzania. An analysis into the systems, treatment regimes and organisation and company involvement and their interrelations was carried out. Each country's status, with respect to these analyses results, was ascertained. Market dynamics, including challenges, drivers and restraints, were also identified along with potential involvement opportunities.

Table of Contents

Overview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa, Executive SummaryOverview of The Orphan Diseases and Drugs Space in Sub-Saharan AfricaIntroduction to The Orphan Drugs and Diseases Space in Sub-Saharan AfricaOverview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa, Research Aim and ObjectivesOverview of The Research Aims and ObjectivesIntroduction to the Research Aim and ObjectivesOverview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa, Research Scope, Definitions and Exchange RatesOverview of The Research Scope, Definitions and Exchange RatesIntroduction to The Research Scope, Definitions and Exchange RatesOverview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa, Research MethodologyOverview of The Research MethodologyIntroduction to The Research MethodologyOverview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa, Orphan Drugs and Diseases in Sub-Saharan Africa – An IntroductionOverview of Orphan Drugs and Diseases in Sub-Saharan AfricaAn Introduction to Orphan Drugs and Diseases in Sub-Saharan AfricaOverview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa, Neglected Diseases in Sub-Saharan AfricaOverview of Neglected Diseases in Sub-Saharan AfricaIntroduction to the Neglected Diseases in Sub-Saharan AfricaOverview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa, Orphan Drug and Program OverviewOverview of Orphan Drugs and Their Disrtibution ProgramsIntroduction to Orphan Drugs and Their Distribution ProgramsOverview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa, Country Analysis: GhanaOverview of GhanaIntroduction to GhanaOverview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa, Country Analysis: NigeriaOverview of NigeriaIntroduction to NigeriaOverview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa, Country Analysis: UgandaOverview of UgandaIntroduction to UgandaOverview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa, Country Analysis: KenyaOverview of KenyaIntroduction to KenyaOverview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa, Country Analysis: TanzaniaOverview of TanzaniaIntroduction to TanzaniaOverview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa, ConclusionsConclusion OverviewIntroduction to ConclusionsOverview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa, AppendixAppendix OverviewIntroduction to the AppendixOverview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa, About Frost & SullivanOverview of The Orphan Disease and Drug Space in Sub-Saharan AfricaIntroduction to Frost & Sullivan




Related Research

The Future of Patient Engagement 2.0 in Europe, 2018

Release Date : 30-Nov-18

Region : Europe

PCHA and Partners HealthCare Connected Health Conference, 2018

Release Date : 21-Nov-18

Region : North America

Innovations in Medical Device Cybersecurity Solutions, ECG Monitoring, Artificial Chordae Delivery Systems, Implantable Pulse Generators, Mobile Health Platforms, Teleconsultation Services, and Laser Endomicroscopy

Release Date : 16-Nov-18

Region : Global

Companion Diagnostics: Biomarker Platforms Enabling Precision Medicine

Release Date : 13-Nov-18

Region : Global

Artificial Intelligence Revolutionizing the Pharmaceutical Industry

Release Date : 13-Nov-18

Region : Global

Innovations Involving Use of Quantum Dots in Life Science, Advanced Drug Discovery Platforms, and AAV-vector Manufacturing

Release Date : 09-Nov-18

Region : Global

Growth Opportunities in the Global Medical Imaging Artificial Intelligence Market, Forecast to 2022

Release Date : 30-Oct-18

Region : North America

Innovations in Defibrillators, Disinfection Systems, Orthopedic Implant Designing System, Alzheimer’s Detection, Breast Cancer Diagnosis, and Drug-eluting Stents

Release Date : 19-Oct-18

Region : Global

Unveiling the Potential of Novel Life Sciences Platforms in Stem Cells, Microbiome, Computational Genomics, and Advanced Diagnostics

Release Date : 12-Oct-18

Region : Global

Technology Growth Series--Market Trends and Emerging Opportunities for Visualization

Release Date : 29-Sep-18

Region : Global

Why Frost & Sullivan

Vision & Strategy

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Brand & Demand

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Technology & IP

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

Global Prespective

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.